BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• 

  Drug Development

  Pfizer’s JAK Inhibitor Xeljanz Racks Up Another FDA Win

  The FDA’s approval of Xeljanz is based on Pfizer’s Phase III multicenter, double-blind, placebo-controlled study. Here are more details about the study.

  December 15, 2021

   · 

  2 min read

   · 

  Vanessa Doctor, RN
• 

  Career Advice

  How to Answer Some Tricky Interview Questions

  It’s no secret that employers ask tricky interview questions. But what do you do if you find yourself fumbling for words to answer these tricky questions?

  December 15, 2021

   · 

  4 min read

   · 

  Hannah Harshman
• 

  Deals

  BeiGene’s Triple Listing Bears Brunt of Escalating U.S.-China Tensions

  Shares of BeiGene have fallen 16% in China in part due to concerns over potential U.S. sanctions against Chinese biotech companies.

  December 15, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  BioMidwest

  Eli Lilly’s Two-Year Ambition Includes Alzheimer’s Approvals

  Eli Lilly and Company’s projections for next year exceed Wall Street projections for the company, predicting 2022 revenue of $27.8 billion to $28.3 billion.

  December 15, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  FDA Greenlights BMS’s Orencia for Acute GVHD – Partly on RWE

  The FDA said Orencia is the first drug approved as prophylaxis for aGVHD prevention that included real-world evidence as one component of clinical efficacy.

  December 15, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Genetown

  Mythic Therapeutics Scores $103 Million to Make “Safer and Smarter” ADCs

  Mythic Therapeutics has roared out of the gate with a $103 million Series B financing round that will support “safer and smarter” next generation of antibody-drug conjugates (ADCs).

  December 15, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Lilly UC Treatment Holds Edge in Maintenance Study, Setting Up BLA

  These results set Lilly up well to submit a Biologics License Application (BLA) in the first half of 2022.

  December 15, 2021

   · 

  3 min read

   · 

  Sreetama Dutt
• 

  Drug Development

  Sanofi/GSK Booster Shot Looking Good But Delayed Until 2022

  Sanofi and GlaxoSmithKline reported that their potential COVID-19 booster shot delivered good immune response in its preliminary clinical trials.

  December 15, 2021

   · 

  2 min read

   · 

  Alvin Clavines
• 

  Global Roundup: Aussie Biopharma Raises $25 Million to Expand in US

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  December 15, 2021

   · 

  7 min read

   · 

  Alex Keown
• 

  Business

  Money on the Move: December 8 – 14

  During a season of giving, investors were extra generous to these biotech companies this week.

  December 15, 2021

   · 

  3 min read

   · 

  Kate Goodwin